首页> 外文期刊>Phosphorus, Sulfur, and Silicon and the Related Elements >Synthesis, spectral, characterization, and anticancer activity of some binary and mixed ligand complexes of 4-methyl-2-pentanone thiosemicarbazone and some amino acids
【24h】

Synthesis, spectral, characterization, and anticancer activity of some binary and mixed ligand complexes of 4-methyl-2-pentanone thiosemicarbazone and some amino acids

机译:4-甲基-2-戊酮硫半碳zone与某些氨基酸的二元和混合配体配合物的合成,光谱,表征和抗癌活性

获取原文
获取原文并翻译 | 示例
       

摘要

The Schiff base ligand 4-methyl-2-pentanone thiosemicarbazone (MPTSC) (HL) has been synthesized by the interaction of 4-methyl-2-pentanone (MP) and thiosemicarbazone (TSC). The Ni(II), Cu(II), and Fe(III) binary complexes of this ligand have been prepared. The ternary complexes of VO(IV) and Mn(II) ions with HL and glutamine (Glu) as a secondary ligand, in addition to VO(IV), Mn(II), and La(III) with HL and glycine (Gly) as a secondary ligand, have also been synthesized. The binary and ternary complexes have been characterized based on elemental analysis, IR, UV-VIS, molar conductance, mass spectra, magnetic moment, and ESR measurements. The magnetic moment, UV, and ESR studies suggest that Ni(II) and Cu(II) complexes are square planar, whereas Fe(III), Mn(II), and La(III) complexes have octahedral geometry, but VO(IV) ternary complexes have square pyramidal geometry. The analytical data indicate that the metal-to-ligand ratio in binary complexes is 1:1, except HL-Cu(II) chloride complex where the metal-to-ligand to secondary ligand ratio in ternary complexes is 1:1:1. The anticancer studies showed that the anticancer activity is in the decreasing order: ternary complexes > binary complexes > free ligand (HL).
机译:席夫碱配体4-甲基-2-戊酮硫代半脲(HL)是通过4-甲基-2-戊酮(MP)和硫代氨基脲(TSC)的相互作用合成的。已经制备了该配体的Ni(II),Cu(II)和Fe(III)二元配合物。 VO(IV)和Mn(II)离子与HL和谷氨酰胺(Glu)作为二级配体的三元络合物,以及VO(IV),Mn(II)和La(III)与HL和甘氨酸(Gly)的三元络合物)作为二级配体,也已经合成。基于元素分析,IR,UV-VIS,摩尔电导,质谱,磁矩和ESR测量对二元和三元络合物进行了表征。磁矩,UV和ESR研究表明,Ni(II)和Cu(II)配合物呈正方形平面,而Fe(III),Mn(II)和La(III)配合物具有八面体几何形状,而VO(IV) )三元复合物具有方形金字塔形几何形状。分析数据表明,二元配合物中的金属与配体的比例为1:1,但HL-Cu(II)氯化物配合物除外,其中三元配合物中的金属与配体与第二配体的比例为1:1:1。抗癌研究表明,其抗癌活性呈递减顺序:三元复合物>二元复合物>游离配体(HL)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号